Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Worldwide Endocrine Testing Industry to 2026 - Featuring Abbott Laboratories, DiaSorin and Quest Diagnostics Among Others

DUBLIN, Dec. 2, 2021 /PRNewswire/ -- The "Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, the publisher expects the market to grow at a CAGR of 8.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor.

Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Endocrine Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Test Type
6.1 Thyroid Test
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Insulin Test
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Human Chorionic Gonadotropin Test
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Prolactin Test
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Luteinizing Hormone Test
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Progesterone Test
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast

7 Market Breakup by Technology
7.1 Immunoassay
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Tandem Mass Spectroscopy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sensor Technology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 LC-MS
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End Use
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories Company Overview Product Portfolio Financials SWOT Analysis
14.3.2 Agilent Technologies Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.3 Bio-Rad Laboratories Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.4 BioMerieux SA Company Overview Product Portfolio Financials SWOT Analysis
14.3.5 DiaSorin S.p.A. Company Overview Product Portfolio Financials SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG) Company Overview Product Portfolio SWOT Analysis
14.3.7 Laboratory Corporation of America Holdings Company Overview Product Portfolio Financials SWOT Analysis
14.3.8 Quest Diagnostics Incorporated Company Overview Product Portfolio Financials SWOT Analysis
14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft) Company Overview Product Portfolio Financials SWOT Analysis
14.3.10 Thermo Fisher Scientific Inc. Company Overview Product Portfolio Financials SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/3hfa8z

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 10:25
The "Gastroesophageal Reflux Disease (GERD) Treatment Devices-Market Insights, Competitive Landscape and Market Forecast-2026" report has been added to ResearchAndMarkets.com's offering. The Gastroesophageal Reflux Disease (GERD) Treatment Devices...

at 10:25
Pluribus Technologies Corp. ("Pluribus" or the "Company"), a growing acquiror of small, profitable software companies, today announced that, further to its press release dated January 25, 2022, Pluribus has closed its acquisition of all of the...

at 10:20
AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of "bbb" (Good) of Post-Telecommunication Joint Stock Insurance Corporation (PTI) (Vietnam). The outlook of these Credit Ratings (ratings) is...

at 10:17
B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, today announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical manufacturing plant in Daytona...

at 10:15
The "U.S. Healthcare Denial Management Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The U.S. healthcare denial management market size was valued at USD 3.57 billion in 2021 and is...

at 10:10
AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of "aa-" (Superior) of The Dai-ichi Life Insurance Company, Limited (DL) (Japan), the wholly owned operating subsidiary of Dai-ichi Life...

News published on 2 december 2021 at 13:45 and distributed by: